secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rallybio Corp (RLYB)
CIK:        0001739410
Form:       8-K
Filed at:   2022-08-02T23:59:59+00:00
Accession:  0000950170-22-013744
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rallybio appoints Wendy K. Chung, M.D., Ph.D., to its Board of Directors
------------------------------------------------------------------------

- Board size increased from 9 to 10; Dr. Chung fills newly created vacancy effective Aug 1, 2022.
- Dr. Chung appointed as Class III director with term expiring at 2024 annual meeting.
- She will serve on the Nominating and Corporate Governance Committee.
- Compensation follows standard non-employee director policy; no material transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739410/000095017022013744/0000950170-22-013744-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739410/000095017022013744/rlyb-20220801.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-013744

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer